Page 4 - Lipoproteins News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lipoproteins. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lipoproteins Today - Breaking & Trending Today

Blessing Health offers no-cost cholesterol screening

Registrations are now being taken for Blessing Health’s next no-cost cholesterol screening. ....

Blessing Health , Blessing Resource Center , Health Medical Pharma , Low Density Lipoprotein , Blood Test ,

Muvalaplin and Olpasiran Show Promise in Lowering Lp(a)

Oral muvalaplin lowered lipoprotein(a) in a phase 1 study, and injectable olpasiran did so in an extension of a phase 2 study, both with no adverse safety signals, researchers report. ....

United States , Noord Holland , United Kingdom , South Australia , Eli Lilly , Louise Bowman , Michellel Odonoghue , Stephenj Nicholls , University Of Oxford , European Society Of Cardiology , Harvard Medical School , Medicines Company , American Heart Association Scientific Sessions , Monash University , Victoria Heart Institute , Boehringer Ingelheim , European Society , New England Journal , New Amsterdam Pharma , Ipid Management , Roprotein Convertase Subtilisin Kexin Type 9 , Low Ldl Cholesterol , Ow Low Density Lipoprotein Cholesterol , Body Mass Index Bmi , Cardiovascular Disease , Vd Cardiovascular Disease ,

Fluctuating Lipid Levels Tied to Increased Dementia Risk

Fluctuations in specific blood lipid levels is linked to a significantly increased risk for dementia in new findings that further confirm the well-established link between heart health and brain health. ....

United States , Mayo Clinic In Rochester , Suzette Bielinski , Christopher Weber , Alzheimer Association , Rochester Epidemiology Program , Mayo Clinic , Medscape Medical News , Association Director , Global Science Initiatives , Alzheimers Disease , Lzheimer Disease , Ipid Management , Cognitive Impairment , High Density Lipoprotein Cholesterol , Fdl C , Low Ldl Cholesterol , Ow Low Density Lipoprotein Cholesterol , Medical Records , Medical Records Linkage , Ild Cogniti ,

Steep LDL Cholesterol Reductions With ANGPTL3 siRNA in HoFH

A single injection every 3 months of a novel drug that targets the lipid metabolism enzyme ANGPTL3 resulted in substantial reductions in LDL cholesterol in patients with HoFH in the phase 2 GATEWAY trial. ....

South Africa , Baden Wüberg , G Danilo Norata , Frederickj Raal , Department Of Pharmacological , Lipid Metabolism Research Unit , Biomolecular Sciences , Arrowhead Pharmaceuticals , University Of The Witwatersrand , European Atherosclerosis Society , Drug Administration , University Of Milan , Regeneron Pharmaceuticals , Medscape Cardiology , Ipid Management , Low Ldl Cholesterol , Ow Low Density Lipoprotein Cholesterol , Liver Enzymes , Liver Studies , Roprotein Convertase Subtilisin Kexin Type 9 , High Density Lipoprotein Cholesterol , Fdl C , Genomic Medicine , Edicine Genomic , Genetic Testin ,

Lomitapide Shows Promise in Pediatric Homozygous FH

Children and adolescents with homozygous familial hypercholesterolemia could benefit from lomitapide therapy, suggests a trial, although safety concerns and upcoming novel drugs question its place. ....

Baden Wüberg , Comunidad Autonoma De Cataluna , Amryt Pharma , Luis Masana , Andreas Zirlik , University Of Graz , Drug Administration , Department Of Cardiology , European Atherosclerosis Society , European Medicines Agency , University Heart Center Graz , Vascular Medicine , Metabolism Unit , Sant Joan De Reu University Hospital , University Hospital , Medical University , Medscape Cardiology , Atherosclerosis Society , Ipid Management , Low Ldl Cholesterol , Ow Low Density Lipoprotein Cholesterol , Liver Enzymes , Liver Studies , High Density Lipoprotein Cholesterol , Fdl C , Familial Hypercholesterolemia ,